Cancer patient in Ziopharm drug trial dies after starting treatment

July 15 (Reuters) - A brain cancer patient enrolled in

Ziopharm Oncology Inc's trial has suffered a fatal

cranial bleed a fortnight after starting treatment with the gene

therapy developer's lead experimental drug, according to a

regulatory filing.

Read more